Product Information
NITROFURANTOIN MONO-MCR 100 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3079 per EA under NDC 65862092901. Its NADAC has been published 103 times since Jul 10, 2024.
Strength
25; 75 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862092901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NITROFURANTOIN; NITROFURANTOIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209225On Market Since
3/30/2023
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MONO-MCR 100 MG has been published 103 times since Jul 10, 2024, and over the history we have for it it has declined 41.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3079 per EA |
|---|---|
| All-time high | $0.5238 (Jul 10, 2024) |
| All-time low | $0.2561 (Nov 20, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.3079 |
| Median price | $0.3352 |
| Average price | $0.3461 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 103 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Nitrofurantoin (Monohydrate/Macrocrystals) market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MONO-MCR 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MONO-MCR 100 MG, manufactured by Aurobindo Pharma Limited, is $0.3079 per EA (NDC 65862092901), effective Jun 24, 2026.
How has the price of NITROFURANTOIN MONO-MCR 100 MG changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has declined 41.2%. It has been tracked across 103 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MONO-MCR 100 MG?
Since Jul 10, 2024, the NADAC for NITROFURANTOIN MONO-MCR 100 MG has ranged from a low of $0.2561 (Nov 20, 2024) to a high of $0.5238 (Jul 10, 2024), with a median of $0.3352 per EA.
Are there cheaper alternatives to NITROFURANTOIN MONO-MCR 100 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NITROFURANTOIN MONO-MCR 100 MG, so no direct lower-cost alternative is listed.
Who manufactures NITROFURANTOIN MONO-MCR 100 MG?
NITROFURANTOIN MONO-MCR 100 MG (NDC 65862092901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification